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Splenic infarction is most commonly caused by cardiovascular thromboembolism; how-
ever, splenic infarction can also occur in hematologic diseases, including sickle cell dis-
ease, hereditary spherocytosis, chronic myeloproliferative disease, leukemia, and 
lymphoma. Although 10% of splenic infarction is caused by hematologic diseases, it sel-
dom accompanies autoimmune hemolytic anemia (AIHA). We report a case of a 
47-year-old woman with iron deficiency anemia who presented with pain in the left upper 
abdominal quadrant, and was diagnosed with AIHA and splenic infarction. Protein C activ-
ity and antigen decreased to 44.0% (60-140%) and 42.0% (65-140%), respectively. 
Laboratory testing confirmed no clinical cause for protein C deficiency, such as dis-
seminated intravascular coagulation, sepsis, hepatic dysfunction, or acute respiratory dis-
tress syndrome. Protein C deficiency with splenic infarction has been reported in patients 
with viral infection, hereditary spherocytosis, and leukemia. This is a rare case of splenic 
infarction and transient protein C deficiency in a patient with AIHA.
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INTRODUCTION
Splenic infarction can occur in various diseases; however, 
the incidence is very low. Thromboembolic events associated 
with atrial fibrillation, cardiac surgery, or infective endo-
carditis are well-known causes of splenic infarction. 
Additionally, several hematologic diseases including sickle 
cell anemia, lymphoma, and leukemia can cause splenic in-
farction [1]. Chronic myeloproliferative disease can also lead 
to splenic infarction due to massive splenomegaly and a 
hypercoagulable state [1]. Massive splenomegaly may lead 
to splenic infarction and subsequent splenic rupture.
Autoimmune hemolytic anemia (AIHA), caused by auto-
antibodies binding to the surface of RBCs, is an uncommon 
disease with an incidence of approximately 1-3 cases/100,000 
per year in the general population [2]. In AIHA, massive 
hemolysis causes activation of the immune response, destruc-
tion of RBCs, and splenomegaly [3]. Splenic infarction can 
occur in AIHA, although rarely, and only 2 cases have been 
reported worldwide [4, 5].
Deficiencies of protein C, protein S, and antithrombin 
are well-known risk factors for thromboembolism. Hereditary 
protein C deficiency carries an approximately 10-fold in-
creased risk for venous thrombosis [6]. There have been 
many reports of splenic infarction in patients with protein 
C deficiency [7, 8], and a few of them were accompanied 
by hematologic diseases, such as hereditary spherocytosis 
or acute myeloid leukemia [7, 9].
Although 2 case of splenic infarction with AIHA have 
been reported, neither was accompanied by transient protein 
C deficiency. In this report, we present a rare case of splenic 
infarction and transient protein C deficiency, which occurred 
in a patient with AIHA.Korean J Hematol 2011;46:274-8.
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Table 1. Laboratory tests.
First admission  Second admission 
Hb, Hct (g/dL, %)  3.2, 13.4 7.4, 26.5 
WBC (4-10×10
9/L) 2,460  5,420 
Platelet (150-400×10
9/L) 93,000 87,000 
BUN/Cr (7-25/0.5-1.5 mg/dL)  9/0.5  8/0.5 
Electrolytes (Na/K/Cl, 135-145/3.5-5/98-110 mEq/L) 143/3.3/109  134/3.7/100 
Bilirubin, total (0.2-1.5 mg/dL) 1  2.6 
Bilirubin, direct (0-0.3 mg/dL)  0.3  0.7 
Protein/Albumin (6.3-8.3/3.5-5.3 g/dL)  6, 3.4 7, 3.7
AST, ALT (＜40 IU/L, ＜40 IU/L) 24, 6 32, 3
PT, aPTT (＜1.5 INR, 29-45 sec) 1.2, 43.3  1.16, 44.2 
LDH (90-200 IU/L)  152  711 
Reticulocyte (0.5-2%)  0.17  3.53 
Antineutrophil antibody Negative  ND
Haptoglobin (30-200 mg/dL)  ND 1 
Direct antiglobulin test ND IgG positive/C3d positive
Indirect antiglobulin test  ND IgG positive/C3d negative 
D-dimer (＜500 ng/mL) ND 2,743.86
Fibrinogen (180-400 mg/dL) ND 519
FDP (＜5 μg/mL) ND 5-20
Factor II (65-125%) ND 78
Factor VIII (60-140%) ND 150
Antithrombin (22-39 mg/dL) ND 21.8
Protein C activity (60-140%) ND 44
Protein C antigen (65-140%) ND 41.95
Protein S (0.94-2) ND 2.54
Factor V Leiden ND Negative
Homocysteine (4.7-14.1 μmol/L) ND 6.31
Lupus anticoagulant ND Negative
Anticardiolipin antibody ND IgM positive/ IgG negative
Abbreviation: ND, not done.
CASE REPORT
1. First admission to the hospital
A 47-year-old woman visited our emergency room (ER) 
because of a persistent headache, chills, acute cough, and 
a mild fever for 5 days. Initial examination showed: blood 
pressure, 114/59 mmHg; body temperature, 37.7
oC; pulse 
rate, 102/min; and breathing rate, 20/min. She appeared pale 
and chronically ill. On physical examination, there was no 
specific finding except a palpable spleen in the left upper 
quadrant (LUQ) of the abdomen. She had no notable previous 
medical history except iron deficiency anemia (IDA) due 
to severe menorrhagia, for which she took iron supplements 
for 6 months. Chest X-ray showed mild cardiomegaly, and 
her EKG was normal. The blood tests showed: Hb, 3.2 g/dL; 
Hct, 13.4%; WBCs, 2.4×10
9/L; platelets (PLTs), 93×10
9/L; 
RDW, 21.3%; MCV, 57.3 fL; MCH, 13.7 pg; reticulocytes, 
0.17%; and LDH, 152 IU/L. Iron profiling showed a serum 
ferritin level of 3 ng/mL, a serum iron level of 22 μg/dL, 
and a UIBC of 325 μg/dL. After 2 packs of RBCs were trans-
fused in the ER, her Hb increased to 6.3 g/dL, and her 
general condition improved. She was admitted to our hospital 
for further examination and treatment. Peripheral blood (PB) 
smear showed microcytic hypochromic dysmorphic RBCs, 
including many elliptocytes, schistocytes, and teardrop cells. 
Biochemical tests found: total billirubin, 1 mg/dL; indirect 
bilirubin, 0.3 mg/dL; AST, 24 IU/dL; ALT, 6 IU/dL; BUN, 
9 mg/dL; creatinine, 0.5 mg/dL; Na, 143 mEq/L; K, 3.3 mEq/L; 
and Cl, 109 mEq/L (Table 1). Two blood cultures showed 
no microorganism growth for 5 days. Serological testing for 
Parvovirus was positive for IgG and negative for IgM. Tests 
for antinuclear antibody (ANA) and rheumatoid factor (RF) 
were negative. The stool occult blood test was negative, 
and there was no evidence of blood loss except hyper-
menorrhea. Abdominal CT was performed to rule out gastro-
intestinal malignancy. Abdominal CT showed that spleen 
was enlarged to approximately 17 cm in length of the long 
axis (Fig. 1). A bone marrow biopsy was performed to find 
other causes for pancytopenia and iron-refractory IDA. Bone 
marrow aspiration showed hypercellular marrow with an 
increased M:E ratio (0.7:1). The cellularity of the bone mar-
row was up to 80%. Both erythropoiesis and the number 
of megakaryocytes increased. However, iron storage 
decreased. There were no dysplastic marrow cells or abnor-
mal cell infiltration. On the 12
th hospital day, the patient Korean J Hematol 2011;46:274-8.
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Fig. 1.  (A) Initial abdominal CT 
revealed splenomegaly without 
evidence of splenic infarction. (B)
Follow-up abdominal CT revealed 
a wedge-shaped multifocal low- 
attenuated portions with a well- 
defined margin, suggesting splenic
infarction in a hypertrophic spleen.
Fig. 2. The spleen showing multifocal, well-demarcated, pale, 
wedge-shaped subcapsular infarcts.
was discharged with the Hb level of 7.2 g/dL.
2. Second admission to the hospital
Five days later, the patient revisited the ER due to severe 
abdominal pain in the LUQ. She suffered from acute abdomi-
nal pain after she was discharged, and the pain was 
aggravated. Her blood pressure was 160/80 mmHg, pulse 
rate was 120/min, and breathing rate was 30/min. She was 
not febrile. Physical examination showed that she had direct 
tenderness in the left upper abdomen. Blood tests revealed: 
Hb, 7.4 g/dL; Hct, 26.5%; WBC, 5.4×10
9/L; PLTs, 87×10
9/L; 
MCV, 73.4 fL; and MCH, 20.5 pg. These were nearly identical 
as those at first admittance. However, LDH increased to 
711 IU/L from 152 IU/L, and reticulocytes increased to 3.53% 
from 0.17%. Biochemical testing showed: total billirubin, 
2.6 mg/dL; indirect billirubin, 0.7 mg/dL; AST, 32 IU/L; and 
ALT, 3 IU/L (Table 1). Both PT and aPTT were within 
the normal range. A PB smear showed normocytic normo-
chromic RBCs with spherocytes, elliptocytes, and teardrop 
cells. Haptoglobin decreased to 1 mg/dL (30-200 mg/dL) 
and D-dimer increased to 2,743 ng/mL (0-500 ng /mL). Under 
suspicion of hemolytic anemia, direct antiglobulin tests 
(DAT) and indirect antiglobulin tests (IAT) were performed. 
The DAT for IgG and C3d and the IAT for IgG were positive, 
but the IAT for C3d was negative. Flow cytometry for parox-
ysmal nocturnal hemoglobinuria (PNH) was within the nor-
mal range. She was diagnosed with AIHA. EKG showed 
sinus tachycardia. Abdominal CT showed that the spleen 
had increased to 20 cm and new multiple splenic infarctions 
were observed compared with the previous CT. However, 
thrombosis of blood vessels, including the splenic artery, 
was not observed (Fig. 1). Transthoracic echocardiography 
showed no intracardiac vegetation or thrombus.
To rule out a hypercoagulable status, the activity of protein 
C and S and antigen level were measured. Protein C activity 
and antigen level decreased to 44.0% (60-140%) and 42.0% 
(65-140%), respectively, and protein S activity and antigen 
level were within the normal range. Antithrombin was with-
in the normal range at 21.8 mg/dL (22-39 mg/dL). No Factor 
V Leiden mutation or lupus anticoagulant antibody was 
present. Anticardiolipin antibody IgG was negative, but IgM 
was positive. Serologic tests for cytomegalovirus, Epstein- 
Barr virus, HIV, and hepatitis B and C virus were performed. 
Anti-EBV viral capsid IgM (anti-EBV-VCA IgM) was equivo-
cal, and all others were negative. Anti EBV-VCA IgG was 
negative, and EBNA was not checked.
On the second hospital day, a splenectomy was performed 
due to the uncontrolled, severe left upper abdominal pain. 
On the cross section, the spleen showed multifocal 
wedge-shaped subcapsular infarcts. On microscopic exami-
nation, there was no evidence of lymphoma or leukemic 
infiltration (Fig. 2). After splenectomy, her symptoms and 
pancytopenia improved. Two weeks later, complete blood 
counts showed a full recovery: Hb, 12.1 g/dL; WBCs, 
6.9×10
9/L; PLTs, 629×10
9/L; and reticulocytes, 1.37%.
After discharge, her protein C activity was 109.0% 
(60-140%) and antigen level was 132% (65-140%). The pa-
tient has been under observation at the outpatient center.
DISCUSSION
AIHA is a relatively uncommon disorder that leads to 
hemolysis due to autoantibodies against RBC membrane 
antigens. These autoantibodies can be confirmed by DAT 
and IAT. If intravascular hemolysis is present, schistocytes, Korean J Hematol 2011;46:274-8.
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microspherocytes, and elliptocytes are observed in the PB 
smear, and hemoglobin is detected in the plasma and urine. 
Both hemolysis and autoantibodies should be found for a 
diagnosis of AIHA. Splenic infarction is often associated with 
hemolytic diseases, including sickle hemoglobinopathies, 
myelofibrosis, polycythemia vera, leukemia, and lymphoma. 
However, splenic infarction is rare in AIHA [1].
At first admission, we concluded that IDA was the only 
cause of anemia, even though the presence of hypercellular 
marrow and splenomegaly was sufficient to consider hemo-
lytic anemia. Prolonged IDA might have suppressed hemol-
ysis, because the number of RBCs was decreased in the PB 
and RBC maturation was impaired in bone marrow. After 
transfusion and iron supplementation, hemolysis was trig-
gered and accelerated. Massive hemolysis occurred and sple-
nomegaly was aggravated due to the overload. Finally, the 
spleen was infracted and she returned to the hospital again.
The most common cause of splenic infarction is car-
diovascular thromboembolism, accounting for 22% of cases. 
Thrombophilia, such as protein C deficiency, protein S defi-
ciency, antithrombin deficiency, antiphospholipid syn-
drome, hyperhomocysteinemia, and factor V Leiden muta-
tion, is the second most common cause of splenic infarction. 
The third most common cause is hematologic diseases, in-
cluding sickle hemoglobinopathies, myelofibrosis, PNH, pol-
ycythemia vera, leukemia, and lymphoma, which account 
for 10% of splenic infarctions [1]. In cardiovascular throm-
boembolism or thrombophilia, splenic infarction occurs with 
multiple embolic events involving the lung, kidney, heart, 
and intestine. However, in hematologic diseases, splenic in-
farction is generally limited to the spleen. Therefore, the 
mechanism of splenic infarction in hematologic malignancy 
differs from that in cardiovascular thromboembolism or 
thrombophilia.
Protein C is a vitamin K-dependent protein synthesized 
in the liver that circulates as an inactivated form in the 
blood stream. It is activated by binding to thrombin, and 
then it reduces the coagulation activity of factor Va and 
VIIIa. Because protein C has a crucial function in coagulation, 
protein C deficiency increases the risk of thrombosis. 
Hereditary protein C deficiency is usually inherited as an 
autosomal dominant trait. Acquired protein C deficiency 
is seen in patients with liver diseases, severe infections, septic 
shock, disseminated intravascular coagulation (DIC), or acute 
respiratory distress syndrome (ARDS) [7]. Protein C defi-
ciency has also been reported in some hematologic diseases, 
such as AML and hereditary spherocytosis [7, 9, 10]. In 
active AML patients, protein C level and activity were lower 
than those in normal control individuals or cured AML pa-
tients [10]. In one patient with AML who presented with 
multiple infarctions of the spleen, kidney, and intestine, 
protein C level was transiently decreased during induction 
chemotherapy, but was normalized after complete remission 
was achieved [7]. In hematologic diseases, protein C defi-
ciency can occur asymptomatically and transiently, even 
without evidence of DIC, liver disease, sepsis, or ARDS [7]. 
It is unclear whether transient protein C deficiency increased 
the risk of a subsequent thromboembolic event in hemato-
logic diseases.
In our case, the patient had no liver disease, severe in-
fection, sepsis, or ARDS, and did not have a DIC condition. 
Antithrombin was mildly decreased; however, PT, aPTT, 
and fibrinogen were within the normal range. Although 
D-dimer was elevated, the test is nonspecific, and it can 
be increased in many conditions, including immune-medi-
ated hemolytic anemia. Although PLTs were slightly reduced 
(87×10
9/L), thrombocytopenia might result from splenic se-
questration and severe BM suppression rather than DIC. 
There was no evidence that she had severe infection or 
sepsis.
There have been a few reports on splenic infarction asso-
ciated with viral infections such as CMV or EBV [9, 11-13]. 
In acute viral infection, antiphospholipid antibody is tran-
siently induced and contributes to the outbreak of throm-
boembolism in multiple organs [12, 14]. Another proposed 
cause of splenic infarction in viral infection is that the spleen 
becomes hypertrophied to remove EBV-infected B cells, and 
thus becomes relatively hypoxic [11].
Based on the present case, some possible mechanisms for 
splenic infarction in patients with hemolytic anemia can 
be proposed. Firstly, the sudden blood transfusion and iron 
supplementation triggered hemolysis, and the spleen was 
overloaded. The size of spleen quickly increased, which could 
have led to breakage of blood vessels and the parenchyma 
of the spleen. Secondly, the spleen could have been vulner-
able to hypoxic injury, because it was already in a prolonged 
anemic condition. Thirdly, the transient decreases in protein 
C activity and antigen could have contributed to a throm-
boembolic tendency in the microvasculature of the spleen. 
Fourthly, massive hemolysis facilitated release of procoagu-
lant and/or alteration of erythrocyte morphology [15]. This 
could have caused a further increase in thrombosis. The 
final possible cause is a hidden viral infection that aggravates 
the hemolytic anemia and induces proliferation of infected 
cells. The patient’s initial presentations were headache and 
fever; but, there was no evidence of bacterial infection. Her 
symptoms were self-limiting and did not require anti-
microbial treatment. Anti EBV-VCA IgM was equivocally 
positive, IgG was negative, and EBNA was not checked. 
Although these findings are not fully compatible with active 
EBV infection, they also could not rule out viral infection. 
According to the literature, antiphospholipid antibody can 
be produced during viral infection. In this case, anti-
cardiolipin IgM was positive, but IgG was negative. Hidden 
viral infections, such as EBV infection, might be accompanied 
by AIHA, and could aggravate the hemolysis in AIHA.
Splenectomy was inevitable due to the severe, intolerable 
pain in the left upper abdomen. According to the literature, 
splenic infarction may result in significant morbidity and 
mortality and requires immediate diagnosis and treatment 
[1]. Therefore, it is important to immediately recognize 
splenic infarction in patients with predisposing diseases.
We report a patient with AIHA, splenic infarction, and 
transient protein C deficiency, who was misdiagnosed as Korean J Hematol 2011;46:274-8.
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having IDA at first admission. Further examination of possi-
ble hemolytic anemia is recommended, if splenomegaly 
and/or abnormal PB findings are present in patients with 
hypochromic microcytic anemia.
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